×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Pr Benoit You

18:30
Introduction
 
 
18:35
Prise en charge actuelle du cancer de l’ovaire et intérêt de KELIM
Pr Benoit You
 
18:55
Rôle des lymphocytes infiltrants tumoraux (TIL) et du score de réponse à la chimiothérapie (CRS)
Dr Pierre-Alexandre Just
 
19:15
Intérêt des tests HR et de RAD51
Dr Alexandra Leary
 
 
19:35
Applications pratiques des nouveaux outils et débat/discussion - Réponses aux questions
Ensemble des intervenants
 
  
Shooting date : 2022-05-18
Last update : 2022-05-20

Suggestions

Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT-8)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT-5)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT-3)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+10)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+12)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT-10)
San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT-7)
New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT-4)
Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT-3)
Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT)
London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+3)
Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+4)
Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+7)
Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+8)
Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+9)
Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+11)
Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+13)

Prise en charge des carcinomes séreux de bas grade en 2023

Share
Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT-10)
San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT-7)
New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT-4)
Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT-3)
Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT)
London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+1)
Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+3)
Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+4)
Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+7)
Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+8)
Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+9)
Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+11)
Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+13)

Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

Cycle d'enseignement sur le cancer de l'ovaire - Première session

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT-10)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT-8)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT-5)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT-3)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+2)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+4)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+7)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+8)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+9)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+10)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+12)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up